G2B Pharma, Inc. — Form D

G2B Pharma, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-06-11. The offering totals $235K, of which $235K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2013-06-11
• Form: D
• Accession: 0001578421-13-000001
• Industry: Biotechnology
• Exemptions: 04
• Total offering: $235K
• Amount sold: $235K
• Minimum investment: $3K
• Investors: 14
• Date of first sale: 2013-05-31
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-197749

Issuer

• Name: G2B Pharma, Inc.
• CIK: 0001578421
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2009
• Address: 474 LIBERTY ST., SAN FRANCISCO, CA, 94114
• Phone: 415-5056099

Officers, directors & promoters (1)

More

• CIK 1578421 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search